| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 15 |
| 1 | CYCLOPHOSPHAMIDE | 7 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 7 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 7 |
| 4 | CYTARABINE | 6 |
| 5 | FLUDARABINE PHOSPHATE | 6 |
| 6 | METHOTREXATE | 5 |
| 7 | METHOTREXATE SODIUM | 5 |
| 8 | DEXAMETHASONE | 3 |
| 9 | DEXAMETHASONE 1.5 MG | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 15 | 0.0014 |
| 1 | INOTUZUMAB OZOGAMICIN | 2 | 0.0007 |
| 2 | NICARDIPINE HYDROCHLORIDE | 1 | 0.0004 |
| 3 | CLOFARABINE | 1 | 0.0004 |
| 4 | FOSCARNET SODIUM | 1 | 0.0002 |
| 5 | NICARDIPINE | 1 | 0.0002 |
| 6 | PEGASPARGASE | 2 | 0.0002 |
| 7 | MITOXANTRONE HYDROCHLORIDE | 1 | 0.0002 |
| 8 | FLUDARABINE PHOSPHATE | 6 | 0.0002 |
| 9 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 1 | Asparagine-specific Enzyme [EPC] | 2 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Topoisomerase Inhibitor [EPC] | 3 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 7 | General Anesthetic [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |